Key Research Institutions & Investigators Novo Nordisk (developer and trial sponsor) University of Copenhagen (metabolic research center) Yale University (Dr

Moderator: - Venkata Narayana Tanniru, President Indian Pharmaceutical Association, FIP South-East Asian Pharmaceutical Forum (SEARPharm Forum), India Panellists: - Jagdish Kaur, Regional Adviser, Tobacco Free initiative, Southeast Asia Regional Office of the World Health Organization (WHO SEARO), India - Vindya Pathiraja, Head of the Department and Senior Lecturer University of Ruhuna and Pharmaceutical Society of Sri Lanka, Sri Lanka - Audrey Clarissa, Vice Secretary General, Ikatan Apoteker, Indonesia - Wirat Tongrod, Lecturer, Faculty of Pharmaceutical Sciences, Huachiew Chalermprakiet University, Thailand - Ins Nunes da Cunha, FIP Practice Development and Transformation Projects Manager FIP, The Netherlands Watch video Digital event video 25 June 2024, 10:00 - 11:30 CEST Empowering pharmacists to support tobacco cessation in Western Pacific Region More In the Western Pacific Region, 22.5 % of people aged 15 years and over were current tobacco users

GLP-1 medications work by slowing digestion and reducing appetite, which means they can meaningfully change how much and how often you eat
For instance, a user mentioned losing 8 pounds after 1 week and 2 days on Wegovy, starting with a 0.25 dosage